51˶

Primary Care

Obesity

More in Obesity

FDA Approves First Sleep Apnea Drug

Tirzepatide ok'd for obstructive sleep apnea in people with obesity

Dec 20, 2024
FDA APPROVED tirzepatide (Zepbound) over a photo of a sleep apnea mask.
FDA Says Compounded Tirzepatide Must Exit the Market

Compounders only have 2 to 3 months left to copy injectable

Dec 19, 2024
A photo of a Mounjaro injection pen sitting on a box of four.
Opinion
A New Fad: Microdosing Ozempic

Why it's unlikely to help most people

Dec 11, 2024
A photo of a woman self-injecting in her thigh with a semaglutide pen.
More Beans, Less Red Meat: Nutritionists Weigh in on U.S. Dietary Guidelines

Advisory panel had no conclusions about ultraprocessed foods or alcohol

Dec 10, 2024
A photo of various cuts of beef and pork are displayed for sale at a discount market in Arlington, Virginia.
RFK Jr. to Investigate Vaccines; Microdosing Semaglutide; Methadone Clinic Fraud?

Health news and commentary gathered by 51˶ staff

Dec 09, 2024
Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.
Opinion
Are GLP-1 Drug Holidays a Risk Worth Taking?

Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care

Dec 08, 2024
image
Women's CVD Risk Calculations Barely Budge When Sex-Specific Variables Are Included

Existing models improved only slightly after accounting for certain female risk factors

Dec 06, 2024
A computer rendering of atherosclerosis.
Should Pharmaceutical Companies Sell Weight-Loss Drugs Directly to Consumers?

Physicians, policymakers raise questions about LillyDirect connecting patients with telehealth

Dec 06, 2024
A photo of a woman holding a smartphone which is displaying the Eli Lilly logo.
Opinion
Untangling GLP-1 Risks: Are Side Effects Overblown?

Experts tackle myths, data bias, and game-changing outcomes of obesity drugs

Dec 05, 2024
image
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says

Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide

Dec 04, 2024
A photo of a tirzepatide (Zepbound) injection pen over an out of focus photo of a barbell wrapped in a measuring tape and a s
Opinion
GLP-1s: The Medications Redefining Diabetes and Obesity Treatment

Experts tackle access, equity, and the blockbuster drugs reshaping healthcare

Dec 04, 2024
image
Benefits of HPV Vaccination; Contraindications to Newer Obesity Drugs

Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines

Nov 30, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
Biden Proposes Coverage of Obesity Drugs in Medicare, Medicaid

Federal government would pick up about three-fourths of the cost for Medicaid coverage

Nov 26, 2024
Semaglutide (GLP-1) weight-loss drug Wegovy
Are GLP-1 Drugs Putting an End to Bariatric Surgery?

A conversation with bariatric surgeon Christine J. Ren-Fielding, MD

Nov 26, 2024
 A screenshot of the YouTube video.
More in Obesity